Hearing loss in autoimmune disorders: Prevalence and therapeutic options

Patrizia Mancini, Francesca Atturo, Alessia Di Mario, Ginevra Portanova, Massimo Ralli, Armando De Virgilio, Marco de Vincentiis, Antonio Greco

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

The objective of this study was to review our current knowledge relative to the correlation between sensorineural hearing loss (SNHL) and autoimmune diseases, focusing on the prevalence of hearing loss in different pathologies and possible therapeutic approaches. A review of the literature on hearing loss in different forms of autoimmune disease has been carried out, with emphasis on incidence and prevalence of SNHL. Therapeutic protocols have been assessed including both conservative medical and rehabilitative methods. Cochlear implant outcomes have been investigated. The prevalence of hearing loss in autoimmune and immune-mediated inner ear diseases, as referred by case reports or single-center statistics, is widely variable. More difficult is the evaluation of severe/profound SNHL, usually reported in relation to cochlear implantation. Though these patients represent ideal candidates for cochlear implantation, as they become deaf after years of hearing; the associated systemic disease, the specific damage on inner ear structures and the medication taken may influence the result of cochlear implantation. The main problem is the cochlear fibrosis or ossification that has been found to affect 50% of implanted ears in patients suffering from autoimmune and immune-mediated SNHL. Hence, in the presence of severe/profound SNHL earlier implantation may be indicated before post-inflammatory obliterative changes to the cochlea.

Original languageEnglish
Pages (from-to)644-652
Number of pages9
JournalAutoimmunity Reviews
Volume17
Issue number7
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Sensorineural Hearing Loss
Hearing Loss
Cochlear Implantation
Cochlea
Autoimmune Diseases
Labyrinth Diseases
Therapeutics
Cochlear Implants
Inner Ear
Osteogenesis
Hearing
Ear
Fibrosis
Pathology
Incidence

Keywords

  • Autoimmune inner ear disease
  • Cochlear implant
  • Hearing loss
  • Immune-mediated inner ear disease

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Hearing loss in autoimmune disorders : Prevalence and therapeutic options. / Mancini, Patrizia; Atturo, Francesca; Di Mario, Alessia; Portanova, Ginevra; Ralli, Massimo; De Virgilio, Armando; de Vincentiis, Marco; Greco, Antonio.

In: Autoimmunity Reviews, Vol. 17, No. 7, 01.07.2018, p. 644-652.

Research output: Contribution to journalReview article

Mancini, P, Atturo, F, Di Mario, A, Portanova, G, Ralli, M, De Virgilio, A, de Vincentiis, M & Greco, A 2018, 'Hearing loss in autoimmune disorders: Prevalence and therapeutic options', Autoimmunity Reviews, vol. 17, no. 7, pp. 644-652. https://doi.org/10.1016/j.autrev.2018.01.014
Mancini, Patrizia ; Atturo, Francesca ; Di Mario, Alessia ; Portanova, Ginevra ; Ralli, Massimo ; De Virgilio, Armando ; de Vincentiis, Marco ; Greco, Antonio. / Hearing loss in autoimmune disorders : Prevalence and therapeutic options. In: Autoimmunity Reviews. 2018 ; Vol. 17, No. 7. pp. 644-652.
@article{1f5f868edd0e4d1a8917c9c2e3c99943,
title = "Hearing loss in autoimmune disorders: Prevalence and therapeutic options",
abstract = "The objective of this study was to review our current knowledge relative to the correlation between sensorineural hearing loss (SNHL) and autoimmune diseases, focusing on the prevalence of hearing loss in different pathologies and possible therapeutic approaches. A review of the literature on hearing loss in different forms of autoimmune disease has been carried out, with emphasis on incidence and prevalence of SNHL. Therapeutic protocols have been assessed including both conservative medical and rehabilitative methods. Cochlear implant outcomes have been investigated. The prevalence of hearing loss in autoimmune and immune-mediated inner ear diseases, as referred by case reports or single-center statistics, is widely variable. More difficult is the evaluation of severe/profound SNHL, usually reported in relation to cochlear implantation. Though these patients represent ideal candidates for cochlear implantation, as they become deaf after years of hearing; the associated systemic disease, the specific damage on inner ear structures and the medication taken may influence the result of cochlear implantation. The main problem is the cochlear fibrosis or ossification that has been found to affect 50{\%} of implanted ears in patients suffering from autoimmune and immune-mediated SNHL. Hence, in the presence of severe/profound SNHL earlier implantation may be indicated before post-inflammatory obliterative changes to the cochlea.",
keywords = "Autoimmune inner ear disease, Cochlear implant, Hearing loss, Immune-mediated inner ear disease",
author = "Patrizia Mancini and Francesca Atturo and {Di Mario}, Alessia and Ginevra Portanova and Massimo Ralli and {De Virgilio}, Armando and {de Vincentiis}, Marco and Antonio Greco",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.autrev.2018.01.014",
language = "English",
volume = "17",
pages = "644--652",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "7",

}

TY - JOUR

T1 - Hearing loss in autoimmune disorders

T2 - Prevalence and therapeutic options

AU - Mancini, Patrizia

AU - Atturo, Francesca

AU - Di Mario, Alessia

AU - Portanova, Ginevra

AU - Ralli, Massimo

AU - De Virgilio, Armando

AU - de Vincentiis, Marco

AU - Greco, Antonio

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The objective of this study was to review our current knowledge relative to the correlation between sensorineural hearing loss (SNHL) and autoimmune diseases, focusing on the prevalence of hearing loss in different pathologies and possible therapeutic approaches. A review of the literature on hearing loss in different forms of autoimmune disease has been carried out, with emphasis on incidence and prevalence of SNHL. Therapeutic protocols have been assessed including both conservative medical and rehabilitative methods. Cochlear implant outcomes have been investigated. The prevalence of hearing loss in autoimmune and immune-mediated inner ear diseases, as referred by case reports or single-center statistics, is widely variable. More difficult is the evaluation of severe/profound SNHL, usually reported in relation to cochlear implantation. Though these patients represent ideal candidates for cochlear implantation, as they become deaf after years of hearing; the associated systemic disease, the specific damage on inner ear structures and the medication taken may influence the result of cochlear implantation. The main problem is the cochlear fibrosis or ossification that has been found to affect 50% of implanted ears in patients suffering from autoimmune and immune-mediated SNHL. Hence, in the presence of severe/profound SNHL earlier implantation may be indicated before post-inflammatory obliterative changes to the cochlea.

AB - The objective of this study was to review our current knowledge relative to the correlation between sensorineural hearing loss (SNHL) and autoimmune diseases, focusing on the prevalence of hearing loss in different pathologies and possible therapeutic approaches. A review of the literature on hearing loss in different forms of autoimmune disease has been carried out, with emphasis on incidence and prevalence of SNHL. Therapeutic protocols have been assessed including both conservative medical and rehabilitative methods. Cochlear implant outcomes have been investigated. The prevalence of hearing loss in autoimmune and immune-mediated inner ear diseases, as referred by case reports or single-center statistics, is widely variable. More difficult is the evaluation of severe/profound SNHL, usually reported in relation to cochlear implantation. Though these patients represent ideal candidates for cochlear implantation, as they become deaf after years of hearing; the associated systemic disease, the specific damage on inner ear structures and the medication taken may influence the result of cochlear implantation. The main problem is the cochlear fibrosis or ossification that has been found to affect 50% of implanted ears in patients suffering from autoimmune and immune-mediated SNHL. Hence, in the presence of severe/profound SNHL earlier implantation may be indicated before post-inflammatory obliterative changes to the cochlea.

KW - Autoimmune inner ear disease

KW - Cochlear implant

KW - Hearing loss

KW - Immune-mediated inner ear disease

UR - http://www.scopus.com/inward/record.url?scp=85047369123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047369123&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2018.01.014

DO - 10.1016/j.autrev.2018.01.014

M3 - Review article

C2 - 29729446

AN - SCOPUS:85047369123

VL - 17

SP - 644

EP - 652

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 7

ER -